Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease (ADAPT-PD) China Study
RecruitingNCT07216976Phase: NAStarted 2025-11-19
Summary
The purpose of the study is to evaluate the effectiveness of the Medtronic Adaptive DBS therapy (aDBS) for Parkinson's Disease in China with the Percept family of Implantable Neurostimulators (Percept
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
None
Locations
Xuanwu HospitalBeijing, Beijing Municipality, China
Sun Yat-sen HospitalGuangzhou, Guangdong, China
Huashan HospitalShanghai, Shanghai Municipality, China
Ruijin HospitalShanghai, Shanghai Municipality, China
West China HospitalChengdu, Sichuan, China
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT07216976